Gain Therapeutics (GANX) Accumulated Expenses (2020 - 2026)
Gain Therapeutics' Accumulated Expenses came in at $554,443 for Q2 2026, up 1.3% from $547,270 a year earlier but down 3.4% from the prior quarter.
Powered by 
Analysis
Gain Therapeutics (GANX) Accumulated Expenses (2020 - 2026) Analysis & Trends
At the end of FY2025, Gain Therapeutics' Accumulated Expenses was $518,856, up 50.8% from FY2024.
- Accumulated Expenses carries a five-year compound annual growth rate of 6.5% (FY2020 to FY2025).
- Going back by year, Accumulated Expenses was $344,138 in FY2024 (-41.5%), $588,433 in FY2023 (-45.6%), $1.08 million in FY2022 (+58.7%) and $681,770 in FY2021 (+79.8%).
- The five-year range for quarterly Accumulated Expenses is $344,138 (Q4 2024) to $2.07 million (Q3 2022).
- Year-over-year, Accumulated Expenses has increased for four consecutive quarters, with an average decline of 15.3% over the last eight quarters.
- The fastest year-over-year change in Accumulated Expenses over five years came in Q2 2022 (growth of 229.3%), and the weakest in Q2 2025 (a decline of 68.6%).
- Business Quant data shows GANX's Accumulated Expenses at $574,244 (Q1 2026), $518,856 (Q4 2025) and $735,238 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn |
| 10 | Gain Therapeutics | 54.89 Mn | -4.40 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 554,443.00 |
| Mar 31, 2026 | 574,244.00 |
| Dec 31, 2025 | 518,856.00 |
| Sep 30, 2025 | 735,238.00 |
| Jun 30, 2025 | 547,270.00 |
| Mar 31, 2025 | 413,488.00 |
| Dec 31, 2024 | 344,138.00 |
| Sep 30, 2024 | 673,811.00 |
| Jun 30, 2024 | 1.74 Mn |
| Mar 31, 2024 | 1.10 Mn |
| Dec 31, 2023 | 588,433.00 |
| Sep 30, 2023 | 1.34 Mn |
| Jun 30, 2023 | 1.75 Mn |
| Mar 31, 2023 | 1.26 Mn |
| Dec 31, 2022 | 1.08 Mn |
| Sep 30, 2022 | 2.07 Mn |
| Jun 30, 2022 | 1.07 Mn |
| Mar 31, 2022 | 656,469.00 |
| Dec 31, 2021 | 681,770.00 |
| Sep 30, 2021 | 1.47 Mn |
API Access
Gain Therapeutics Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=GANX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "GANX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=GANX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();